Recurrence after Treatment for Pulmonary Multidrug‐Resistant Tuberculosis
Open Access
- 15 September 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 51 (6), 709-711
- https://doi.org/10.1086/655892
Abstract
We estimated the proportion of recurrence within 2 years among adults cured by individualized multidrug-resistant tuberculosis regimens in Peru. Among 310 individuals with at least 24 months of follow-up, 16 experienced an episode of recurrent tuberculosis. If we assume the worst for treatment effectiveness—that all 16 episodes were caused by the original tuberculosis strain—then 5.2% (95% confidence interval, 3.0%–8.2%) experienced true relapse. This is an upper-bound estimate of relapse on which new regimens must improve.This publication has 4 references indexed in Scilit:
- Treatment Outcomes and Long-term Survival in Patients with Extensively Drug-resistant TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Randomized Trials to Optimize Treatment of Multidrug-Resistant TuberculosisPLoS Medicine, 2007
- Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up studyEuropean Respiratory Journal, 2006
- Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experienceSocial Science & Medicine (1982), 2004